Digestive tract symptoms in congenital langerhans cell histiocytosis: a fatal condition in an illness usually considered benign.

Susanne Vetter-Laracy, Jose Antonio Salinas, Ana Martin-Santiago, Mercedes Guibelalde, Pere-Ramon Balliu

Journal: Journal of pediatric hematology/oncology 2014;36(6):426-9

PMID: 23823119

Abstract

INTRODUCTION

Congenital Langerhans cell histiocytosis is usually limited to cutaneous lesions and has a good prognosis. In rare cases of gut involvement, mortality is high and early and aggressive treatment essential.

MATERIALS AND METHODS

We report a case of histiocytosis in a newborn with bowel involvement, and performed a literature review of 13 similar cases worldwide documented between 1973 and 2008.

RESULTS

Skin eruptions are usually the initial symptoms at birth. Bloody stools or protein-losing enteropathy are the first signs of bowel involvement that appear mostly in the first 4 weeks of life. Risk organs (hematopoietic system, liver, spleen) are often affected in the newborns with intestinal Langerhans cell histiocytosis. Prognosis is usually poor, with 78.5% mortality.

CONCLUSIONS

Even if histiocytosis in a neonate appears limited to autoinvoluting skin lesions, it is important to exclude all other organ involvement, including the bowel and stomach, as early treatment is vital.

Address: *Department of Pediatrics, Division of Neonatology †Department of Pediatrics, Division of Oncology ‡Department of Dermatology, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.